The federal government isn’t considering putting up money to help buy shares in the only domestic manufacturer of COVID-19 vaccines, but it is “working on a solution” with Medicago’s parent company.
While meeting with the presidents of Mitsubishi Tanabe Pharma and Mitsubishi Chemical, which owns a 79 per cent stake in Medicago, Champagne says there were discussions about the company’s future as a global vaccine manufacturer.
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:
Profitable companies don’t deserve my taxes. Stop it.